Johnson Matthey PLC (LON:JMAT - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,470.02 ($18.93) and traded as high as GBX 1,505 ($19.38). Johnson Matthey shares last traded at GBX 1,460 ($18.80), with a volume of 130,870,305 shares changing hands.
Analyst Ratings Changes
A number of analysts have commented on JMAT shares. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 1,800 ($23.17) price target on shares of Johnson Matthey in a research report on Tuesday, December 17th. Berenberg Bank cut their price target on shares of Johnson Matthey from GBX 1,650 ($21.24) to GBX 1,500 ($19.31) and set a "hold" rating on the stock in a report on Thursday, November 28th.
Get Our Latest Stock Report on Johnson Matthey
Johnson Matthey Stock Performance
The company has a market capitalization of £2.39 billion, a PE ratio of 24.30, a PEG ratio of 49,242.50 and a beta of 0.95. The firm has a 50-day moving average of GBX 1,407.05 and a two-hundred day moving average of GBX 1,467.55. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73.
Insider Activity
In related news, insider Liam Condon purchased 30 shares of the company's stock in a transaction that occurred on Wednesday, January 22nd. The shares were purchased at an average price of GBX 1,362 ($17.54) per share, with a total value of £408.60 ($526.07). Also, insider Stephen Oxley acquired 27 shares of Johnson Matthey stock in a transaction on Wednesday, February 19th. The shares were bought at an average price of GBX 1,451 ($18.68) per share, with a total value of £391.77 ($504.40). Insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
